- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01351857
Diabetes Care Management Compared to Standard Diabetes Care in Adolescents and Young Adults With Type 1 Diabetes (TransClin)
7. november 2018 opdateret af: University of Western Ontario, Canada
Multicentre Randomized Controlled Trial of Structured Transition on Diabetes Care Management Compared to Standard Diabetes Care in Adolescents and Young Adults With Type 1 Diabetes
Structured transition program for adolescents and young adults with Type 1 Diabetes (T1D) improves diabetes clinic attendance as well as glycemic control after transition from pediatric to adult diabetes care.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
The purpose of this study is to determine if a structured transition program for adolescents and young adults with Type 1 Diabetes (T1D) improves diabetes clinic attendance and management as well as glycemic control after transition from pediatric to adult diabetes care.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
188
Fase
- Fase 4
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Ontario
-
London, Ontario, Canada, N6A 4V2
- St. Joseph's Health Care
-
London, Ontario, Canada, N6A 5W9
- London Health Sciences Centre - Children's Hospital
-
Mississauga, Ontario, Canada, L5B 1B8
- Trillium Pediatric Diabetes Clinic
-
Ottawa, Ontario, Canada, K1H 8L1
- Children's Hospital of Eastern Ontario
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
17 år til 20 år (Barn, Voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Established T1D diagnosis for a minimum of one year (chosen to allow time for adjustment to a new diagnosis and more stable disease control).
- Between the ages of 17 and 20 years. It is left to the clinical judgment of the pediatric endocrinologist to determine individually the appropriate age of the transition for each subject
- At least 1 visit during the previous year with the pediatric endocrinologist at a Diabetes Clinic (aim is to minimize the non-adherence with the intervention).
- Ability to participate in all aspects of this clinical trial.
- Written informed consent/assent must be obtained and documented.
- Resident of Ontario.
Exclusion Criteria:
- Pregnant or lactating females or intent to become pregnant during the next 3 years.
- Conditions which in the opinion of the investigator may interfere with the subject's ability to participate in the study.
- Prior enrollment in the current study.
- Current participation in another clinical trial or participation in another clinical trial in the 6 months prior to enrollment.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Andet: Transition Coordinator
A Transition Coordinator, a Certified Diabetes Educator, will provide transition support and the link between pediatric and adult diabetes care.
The Transition Coordinator is central to the intervention and will provide ongoing contact with the medical system as well as education and clinical support where appropriate.
|
The Transition Coordinator is central to the intervention and will provide ongoing contact with the medical system as well as education and clinical support where appropriate.
|
Ingen indgriben: Current Standard of Care
Subjects in the control group will transition to adult care equal to the intervention group and will differ only by exclusion of Transition Coordinator.
Control group will receive the current standard of diabetes care otherwise unchanged.
Three months following randomization, subjects in the control group will be referred to the adult endocrinologist in the same way as subjects in the intervention group
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
The proportion of subjects who fail to attend at least one outpatient adult endocrinology visit during the second year after transition to adult diabetes care.
Tidsramme: 30 months
|
30 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
In the 2 year transfer to adult care-Frequency of A1C (glycated hemoglobin test)
Tidsramme: 30 months
|
In the 2 year transfer to adult care-Frequency of A1C (glycated hemoglobin test) & mean levels Frequency of retinal exam microalbumin to creatinine ratio fasting lipid profile and foot exam testing Rate of hospitalization/ER visits for acute complications of diabetes
|
30 months
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Cheril Clarson, MD, London Health Sciences Centre - Children's Hospital
- Ledende efterforsker: Tamara Spaic, St. Joseph's Healthcare Centre
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Generelle publikationer
- Osgood DW, Foster EM, Courtney ME. Vulnerable populations and the transition to adulthood. Future Child. 2010 Spring;20(1):209-29. doi: 10.1353/foc.0.0047.
- Spaic T, Robinson T, Goldbloom E, Gallego P, Hramiak I, Lawson ML, Malcolm J, Mahon J, Morrison D, Parikh A, Simone A, Stein R, Uvarov A, Clarson C; JDRF Canadian Clinical Trial CCTN1102 Study Group. Closing the Gap: Results of the Multicenter Canadian Randomized Controlled Trial of Structured Transition in Young Adults With Type 1 Diabetes. Diabetes Care. 2019 Jun;42(6):1018-1026. doi: 10.2337/dc18-2187. Epub 2019 Apr 22.
- Spaic T, Mahon JL, Hramiak I, Byers N, Evans K, Robinson T, Lawson ML, Malcolm J, Goldbloom EB, Clarson CL; JDRF Canadian Clinical Trial CCTN1102 Study Group. Multicentre randomized controlled trial of structured transition on diabetes care management compared to standard diabetes care in adolescents and young adults with type 1 diabetes (Transition Trial). BMC Pediatr. 2013 Oct 9;13:163. doi: 10.1186/1471-2431-13-163.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. april 2012
Primær færdiggørelse (Faktiske)
28. juni 2017
Studieafslutning (Faktiske)
30. juni 2017
Datoer for studieregistrering
Først indsendt
10. maj 2011
Først indsendt, der opfyldte QC-kriterier
10. maj 2011
Først opslået (Skøn)
11. maj 2011
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
9. november 2018
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
7. november 2018
Sidst verificeret
1. november 2018
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- CCTN1102
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Type 1 diabetes
-
Oxford Brookes UniversityUniversity of OxfordAfsluttetFysisk aktivitet | Mental sundhed velvære 1 | Kognitiv funktion 1, Social | Academic Attainment | Fitness TestingDet Forenede Kongerige
-
Merck Sharp & Dohme LLCRekrutteringIkke-småcellet lungekræft | Faste tumorer | Programmeret celledød-1 (PD1, PD-1) | Programmeret celledød 1 Ligand 1 (PDL1, PD-L1) | Programmeret celledød 1 ligand 2 (PDL2, PD-L2)Japan
-
SanionaAfsluttet
-
Calliditas Therapeutics ABEurofins Optimed; York Bioanalytical SolutionAfsluttet
-
Calliditas Therapeutics ABAfsluttet
-
JKT Biopharma Co., Ltd.Rekruttering
-
Graviton Bioscience CorporationAfsluttet
-
Alvotech Swiss AGAfsluttet
-
PfizerAfsluttet
-
Stony Brook UniversityAfsluttet
Kliniske forsøg med Transition Coordinator
-
University of PennsylvaniaNational Psoriasis FoundationRekrutteringHjerte-kar-sygdomme | Psoriasis | Psoriasisgigt | Psoriatiske tilstandeForenede Stater
-
Johns Hopkins UniversityNational Institute of Mental Health (NIMH); Aurum InstituteAfsluttetHiv | Overholdelse, tålmodigSydafrika
-
University of KansasAfsluttetType 1 diabetesForenede Stater
-
University of Southern CaliforniaThe Leona M. and Harry B. Helmsley Charitable TrustAfsluttetType 1 diabetes mellitusForenede Stater
-
McMaster UniversityRekrutteringInflammatoriske tarmsygdomme | Juvenil idiopatisk arthritisCanada
-
Wake Forest University Health SciencesAfsluttetHospital GenindlæggelseForenede Stater
-
McMaster UniversityWestern UniversityRekrutteringAutoimmune sygdomme | Juvenil idiopatisk arthritis | Juvenil reumatoid arthritis | Autoinflammatorisk sygdom | Juvenil Dermatomyositis | Juvenil psoriasisgigt | Lupus erythematosusCanada
-
Massachusetts General HospitalAfsluttetForhøjet blodtryk | Diabetes | BrystkræftForenede Stater
-
Cambridge Health AllianceAfsluttetPatientudskrivningForenede Stater
-
Saglik Bilimleri UniversitesiAfsluttetAstma hos børnKalkun